Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Margin

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 1.01-1.915.603.92-23.24

What is the latest Core EBITDA Margin ratio of GENPHARMASEC ?

The latest Core EBITDA Margin ratio of GENPHARMASEC is 1.01 based on Mar2023 Standalone results.
Year Core EBITDA Margin
Mar20231.01
Mar2022-1.91
Mar20215.60
Mar20203.92
Mar2019-23.24

How is Core EBITDA Margin of GENPHARMASEC Trending?

Years Core EBITDA Margin % Change
Mar2023 1.01
Positive
Mar2022 -1.91
Negative
Mar2021 5.6
42.86
Mar2020 3.92
Positive
Mar2019 -23.24 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Margin ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹122.4 Cr -3.5% 4.3% 16.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹4,920.7 Cr -0.9% 16.7% 79.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,317.5 Cr -0.4% -0.7% 20% Stock Analytics
KIRI INDUSTRIES ₹1,912.4 Cr -2.4% 16.2% 26.8% Stock Analytics
BODAL CHEMICALS ₹993.1 Cr -1.3% 2.6% 16.9% Stock Analytics
BHAGERIA INDUSTRIES ₹779.5 Cr -1.8% 20.5% 36.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.5%

4.3%

16.2%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses